Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders??? Equity

v3.23.1
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
ESPP
Senior Subordinated Secured Convertible Note
Senior Subordinated Secured Convertible Note
ESPP
Common Stock
Common Stock
Class A and Class B Common Stock
Common Stock
Class A and Class B Common Stock
ESPP
Common Stock
Class A and Class B Common Stock
Senior Subordinated Secured Convertible Note
Additional Paid-in Capital
Additional Paid-in Capital
ESPP
Additional Paid-in Capital
Senior Subordinated Secured Convertible Note
Additional Paid-in Capital
Senior Subordinated Secured Convertible Note
ESPP
Treasury Stock
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Jan. 31, 2020 102,408,000                                
Beginning balance at Jan. 31, 2020 $ 245,970                                
Convertible Preferred Stock                                  
Tender offer repurchases (in shares) (1,407,000)                                
Tender offer repurchases $ (12,730)                                
Issuance of Series G-1 and Series G-2 convertible preferred stock at $9.25 and $11.00 per share, respectively, net of issuance costs (in shares) 19,902,000                                
Issuance of Series G-1 and Series G-2 convertible preferred stock at $9.25 and $11.00 per share, respectively, net of issuance costs $ 191,752                                
Ending balance (in shares) at Jan. 31, 2021 120,903,000                                
Ending balance at Jan. 31, 2021 $ 424,992                                
Beginning balance (in shares) at Jan. 31, 2020           85,626,000 0                    
Beginning balance at Jan. 31, 2020 (14,445)         $ 3 $ 0     $ 50,117       $ (17,957) $ (988) $ (291,590)  
Beginning balance (in shares) at Jan. 31, 2020                           13,376,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Stock-based compensation - equity classified awards 44,159                 44,159              
Exercise of stock options and vesting of restricted shares (in shares)           9,572,000                      
Exercise of stock options and vesting of restricted shares 16,333         $ 1       16,332              
Tender offer repurchases (in shares)           (755,000)               755,000      
Tender offer repurchases (20,390)                 (1,186)       $ (5,874)   (600)  
Issuance of common stock to a third party (in shares)           1,013,000                      
Issuance of common stock to a third party 5,000                 5,000              
Issuance of common stock warrants 7,639                 7,639              
Other comprehensive income (loss) 1,775                           1,775    
Net loss (37,970)                             (37,970)  
Ending balance (in shares) at Jan. 31, 2021           95,456,000 0                    
Ending balance at Jan. 31, 2021 $ 193,853         $ 4 $ 0     122,061       $ (23,831) 787 (330,160)  
Ending balance ( in shares) at Jan. 31, 2021                           14,131,000      
Convertible Preferred Stock                                  
Conversion of convertible preferred stock to common stock upon initial public offering (in shares) (120,903,000)                                
Conversion of convertible preferred stock to common stock upon initial public offering $ (424,992)                                
Ending balance (in shares) at Jan. 31, 2022 0                                
Ending balance at Jan. 31, 2022 $ 0                                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Issuance of common shares (in shares)             18,288,000 552,000                  
Issuance of common shares 275,973   $ 7,105             275,973 $ 7,105            
Conversion of senior subordinated secured convertible notes (in shares)             120,903,000   9,694,000                
Conversion of senior subordinated secured convertible notes 0     $ 82,114     $ 4     424,988   $ 82,114          
Stock-based compensation - equity classified awards 49,827                 49,827              
Reclassification of common stock to Class B common stock (in shares)           (103,045,000) 103,045,000                    
Reclassification of common stock to Class B common stock 0         $ (4) $ 4                    
Exercise of stock options and vesting of restricted shares (in shares)           7,589,000 1,999,000                    
Exercise of stock options and vesting of restricted shares 20,054                 20,054              
Shares issued upon cashless exercise of common stock warrants (in shares)             230,000                    
Issuance of common stock under deferred stock compensation plan (in shares)             1,770,000                    
Other comprehensive income (loss) (1,607)                           (1,607)    
Net loss (111,470)                             (111,470)  
Ending balance (in shares) at Jan. 31, 2022           0 256,481,000                    
Ending balance at Jan. 31, 2022 $ 515,849 $ 761       $ 0 $ 8     982,122       $ (23,831) (820) (441,630) $ 761
Ending balance ( in shares) at Jan. 31, 2022 14,130,784                         14,131,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Accounting standards update, extensible enumeration Accounting Standards Update 2016-13 [Member]                                
Ending balance (in shares) at Jan. 31, 2023 0                                
Ending balance at Jan. 31, 2023 $ 0                                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                  
Issuance of common shares (in shares)               1,259,000                  
Issuance of common shares         $ 10,231     $ 1         $ 10,230        
Stock-based compensation - equity classified awards 57,057                 57,057              
Exercise of stock options and vesting of restricted shares (in shares)             6,014,000                    
Exercise of stock options and vesting of restricted shares 24,740                 24,740              
Other comprehensive income (loss) (3,564)                           (3,564)    
Other adjustments (in shares)             (13,000)                    
Net loss (55,742)                             (55,742)  
Ending balance (in shares) at Jan. 31, 2023           0 263,741,000                    
Ending balance at Jan. 31, 2023 $ 549,332         $ 0 $ 9     $ 1,074,149       $ (23,831) $ (4,384) $ (496,611)  
Ending balance ( in shares) at Jan. 31, 2023 14,130,784                         14,131,000